<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04242277</url>
  </required_header>
  <id_info>
    <org_study_id>PER-19-03</org_study_id>
    <nct_id>NCT04242277</nct_id>
  </id_info>
  <brief_title>Wide-field Optical Coherence Tomography Imaging of Excised Breast Tissue.</brief_title>
  <official_title>Wide-field Optical Coherence Tomography Imaging of Excised Breast Tissue for Evaluation of a Computer-aided Detection Tool, ImgAssistâ„¢.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Perimeter Medical Imaging</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Cancer Prevention Research Institute of Texas</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Perimeter Medical Imaging</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a single-arm, multi-center data collection study designed to collect WF-OCT imaging
      data of excised breast tissue margins with corresponding margin status from histopathology.
      Data collected during this study will be used for product development by the study sponsor,
      Perimeter Medical Imaging.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 20, 2020</start_date>
  <completion_date type="Anticipated">April 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>WF-OCT image acquisition of excised lumpectomy tissue margins</measure>
    <time_frame>1 year</time_frame>
    <description>This is a data collection study. The primary outcome is the collection of WF-OCT images of excised lumpectomy tissue margins.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Breast Cancer Female</condition>
  <arm_group>
    <arm_group_label>WF-OCT imaging of excised breast lumpectomy tissue</arm_group_label>
    <description>Excised lumpectomy tissue from all consented patients will be imaged on an investigational OCT-based device. No clinical decisions will be made based on the images acquired.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Investigational WF-OCT device</intervention_name>
    <description>Excised lumpectomy tissue will be imaged on an investigational WF-OCT device</description>
    <arm_group_label>WF-OCT imaging of excised breast lumpectomy tissue</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Consented patients meeting eligibility criteria, undergoing breast conservation surgery.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Female

          -  Age 18 years or older

          -  Invasive ductal breast carcinoma and ductal carcinoma in situ having undergone breast
             conservation surgery

          -  May include neo-adjuvant treated subjects (chemotherapeutic, endocrine therapy, or
             radiation)

          -  Ability to understand and the willingness to sign a written informed consent document

        Exclusion Criteria:

          -  Metastatic cancer (Stage IV)

          -  Lobular carcinoma as primary diagnosis
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Savitri Krishnamurthy, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>M.D. Anderson Cancer Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Rochelle Keen, RTR(M)</last_name>
    <phone>7179892493</phone>
    <email>rkeen@perimetermed.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>MD Anderson Cancer Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Rochelle Keen</last_name>
      <phone>717-989-2493</phone>
      <email>rkeen@perimetermed.com</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>January 23, 2020</study_first_submitted>
  <study_first_submitted_qc>January 23, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 27, 2020</study_first_posted>
  <last_update_submitted>January 23, 2020</last_update_submitted>
  <last_update_submitted_qc>January 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

